CONSUMERS BANCORP, INC. (CBKM) valuation

Bring your own price

Enter a share price and a discount rate — every multiple, the earning-power value and the reverse-DCF below recompute on the spot from CONSUMERS BANCORP, INC.'s latest SEC EDGAR filings. Change either input and the whole page follows.

$
%
Enter a share price to run the model.

The prefilled 9.6% is a plain CAPM cost of equity at β = 1: the 10-year Treasury yield (5.19%, 2026-10-14, U.S. Treasury 10-yr) plus the U.S. equity risk premium (4.42%, Damodaran 2026-07-01). Build a firmer per-company rate with the cost-of-equity and WACC calculators, then paste it here.

Share price — · awaiting your input

Market Capitalization

Equity value at your price
—

Price-to-Earnings

P/E · Trailing Diluted
—

Earnings Yield

EPS ÷ Price · Trailing
—

Price-to-Free-Cash-Flow

P/FCF · Trailing
—

Free-Cash-Flow Yield

FCF Yield · Trailing
—

Price-to-Sales

P/S · Trailing
—

Price-to-Book

P/B · Latest filing
—

Fundamentals from the filings

Every model input below comes straight from CONSUMERS BANCORP, INC.'s SEC EDGAR XBRL filings — these are the denominators and bridge inputs the calculator pairs with your price and rate.

Trailing twelve months · FY2026 (year ending 2026-06-30)

Revenue
$4.9M
EBIT (GAAP)
$13.2M
EBIT margin
268.2%
Operating cash flow
$11.2M
CapEx
$1.6M
D&A
$1.3M
Free cash flow
$9.6M
YoY revenue growth
6.4%

Balance sheet · 10-K · period ending 2026-06-30

Cash & equivalents
—
Total debt
$30.2M
Stockholders' equity
$89.9M
Preferred stock
$0

Total debt = LineOfCredit ($225.0K) + Short-term borrowings ($29.2M) + Operating lease liability ($810.0K) .

Share count

Diluted shares (TSM-scaled)
3.2M

Method: point-in-time shares outstanding × 1.0001 (latest filer-disclosed diluted ÷ basic ratio). See the diluted-shares methodology for why this count denominates EPV/share and the reverse-DCF equity bridge.

Earning-Power-Value, reverse-DCF, and EV/EBITDA are hidden for this bank. EPV and the reverse-DCF both anchor on an EBIT margin, but a bank's "margin" is interest-spread × leverage with non-EBIT investment results mixed in; EV/EBITDA omits deposits and borrowings — the actual funding — so the multiple isn't interpretable. The trailing multiples above (P/E, P/S, P/B, P/FCF) still render, but the right lens here is price-to-tangible-book-value and ROE vs cost of equity — applied manually, outside this page.

What these ratios mean & how they're built: see the valuation ratios glossary on the Financials methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Fundamentals come from SEC EDGAR XBRL filings for CBKM (CIK 0001006830). The share price and the discount rate are inputs you supply — nothing on this page is a market quote, and the page fetches no market data. Per-share denominators are split-adjusted to today's share count.

Related tickers

HLYK

HealthLynked Corp.

RES

RPC, INC.

ATNM

ACTINIUM PHARMACEUTICALS, INC.